Hepatitis A, B and C prevalence among transgender women and travestis in five Brazilian capitals between 2019-2021

To estimate the prevalence and factors associated with hepatitis A, B, and C in transgender women and travestis's networks, in 5 regions of Brazil. This cross-sectional study includedtransgender women and travestis in five Brazilian capitals (Campo Grande, Manaus, Porto Alegre, Salvador, and Sã...

Full description

Saved in:
Bibliographic Details
Published in:Revista brasileira de epidemiologia Vol. 27Suppl 1; no. Suppl 1; p. e240005.supl.1
Main Authors: Moreira, Regina Célia, Veras, Maria Amélia de Sousa Mascena, Amianti, Carolina, McCartney, Daniel Jason, Silva, Vanessa Cristina Martins, Lemos, Marcilio Figueiredo, Compri, Adriana Parise, Oliveira, Elaine Lopes de, Bassichetto, Katia Cristina, Leal, Andréa Fachel, Knauth, Daniela Ruva, Magno, Laio, Dourado, Inês, Galan, Lenice, Fonseca, Paula Andrea Morelli, Queiroz, Rita Suely Bacuri de, Silva, Roberto José Carvalho da, Araujo, Sandra, Miyachi, Marcia Eiko, Soares, Claudio de Sousa, Ahagon, Luciana Mitie Kawai, Mayaud, Philippe, Sperandei, Sandro, Motta-Castro, Ana Rita Coimbra
Format: Journal Article
Language:English
Portuguese
Published: Brazil Associação Brasileira de Saúde Coletiva 2024
Associação Brasileira de Pós-Graduação em Saúde Coletiva
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To estimate the prevalence and factors associated with hepatitis A, B, and C in transgender women and travestis's networks, in 5 regions of Brazil. This cross-sectional study includedtransgender women and travestis in five Brazilian capitals (Campo Grande, Manaus, Porto Alegre, Salvador, and São Paulo), between December/2019 and July/2021. All samples were subjected to detection of serological markers of hepatitis virus A (HAV), B (HBV), and C (HCV) infections through rapid tests and chemiluminescent microparticle immunoassays. Positive samples in the screening tests were submitted to detect HBV DNA and HCV-RNA by real-time PCR and genotyped by Sanger sequencing. Analysis of 1,317 samples showed network prevalence rates of 69.1%, 25.1%, and 1.5% for HAV, HBV, and HCV exposure, respectively. A high susceptibility rate to HBV infection (35.7%) and low prevalence of vaccine response markers (40%) were also observed. Age greater than 26 years, self-declared black/brown skin color, having only primary education, history of incarceration, and use of a condom in the last sexual intercourse with a casual partner were associated with total anti-HAV. Exposure to HBV was associated with age greater than 26 years, self-declared black/brown, history of being a sex worker, and incarceration. Age > 37 years, history of sexual abuse, and frequent alcohol consumption were associated with hepatitis C infection. The highest prevalence of HAV in this population was found in the North and Northeast regions, and the prevalence found was higher than that in the general population, suggesting greater vulnerability. The prevalence of HCV infection in our study was similar to that observed in the general population.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
CONFLICT OF INTEREST: nothing to declare.
SCIENTIFIC EDITOR: Antonio Fernando Boing 0000-0001-9331-1550
ISSN:1980-5497
1415-790X
1980-5497
DOI:10.1590/1980-549720240005.supl.1